Yilan, Taiwan

Ray Jui-Yuan Chang

This inventor holds 1 USPTO granted patent. Top assignee: National Health Research Institutes. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ray Jui-Yuan Chang. Retrieved from https://idiyas.com/inventor/ray-jui-yuan-chang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ray Jui-Yuan Chang: Innovator in Immunogenic Compositions

Introduction

Ray Jui-Yuan Chang is a notable inventor based in Yilan, Taiwan. He has made significant contributions to the field of immunology, particularly through his innovative work on immunogenic compositions.

Latest Patents

Chang holds a patent for "Immunogenic compositions and uses thereof." This patent discloses methods for producing a purified EV71 virus antigen. It also details related immunogenic compositions and immunization methods, showcasing his expertise in developing effective immunological solutions. He has 1 patent to his name.

Career Highlights

Chang is affiliated with the National Health Research Institutes, where he continues to advance research in health and immunology. His work has implications for vaccine development and public health.

Collaborations

Some of his notable coworkers include Pele Choi-Sing Chong and Chia-Chyi Liu, who contribute to the collaborative efforts in their research endeavors.

Conclusion

Ray Jui-Yuan Chang's innovative work in immunogenic compositions highlights his role as a key figure in the field of immunology. His contributions are vital for advancing health research and vaccine development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…